Ulrich Broeckel
- Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism 22
- Genetics top 1%
- Genetic Associations and Epidemiology 19
- Genomics and Rare Diseases 9
- Inflammatory Bowel Disease 7
-
- Pharmaceutical studies and practices 7
-
- Cardiovascular Function and Risk Factors 7
- Geriatrics and Gerontology top 5%
-
- Hormonal Regulation and Hypertension 7
-
- Drug Transport and Resistance Mechanisms 5
- Co-authors
- Kristine R. CrewsMary V. RellingWilliam E. EvansJames M. HoffmanHeribert SchunkertScott C. HowardDonna K. ArnettHoward J. Jacob
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Ulrich Broeckel
93 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Pharmacology 987
- Genetics 1.5k
- Pediatrics, Perinatology and Child Health 678
- Cardiology and Cardiovascular Medicine 633
- Geriatrics and Gerontology 81
Countries citing papers authored by Ulrich Broeckel
This map shows the geographic impact of Ulrich Broeckel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrich Broeckel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrich Broeckel more than expected).
Fields of papers citing papers by Ulrich Broeckel
This network shows the impact of papers produced by Ulrich Broeckel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrich Broeckel. The network helps show where Ulrich Broeckel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ulrich Broeckel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 8 | |
| 2 | 2023 | 8 | |
| 3 | 2023 | 23 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 11 | |
| 7 | 2021 | 3 | |
| 8 | 2021 | 11 | |
| 9 | 2018 | 90 | |
| 10 | 2016 | 56 | |
| 11 | 2014 | 205 | |
| 12 | 2014 | 43 | |
| 13 | 2012 | 16 | |
| 14 | 2011 | 14 | |
| 15 | 2009 | 36 | |
| 16 | 2006 | 2 | |
| 17 | 2006 | 55 | |
| 18 | 2005 | 8 | |
| 19 | 2000 | 99 | |
| 20 | 1998 | 120 |
About Ulrich Broeckel
Ulrich Broeckel is a scholar working on Pharmacology, Genetics and Clinical Biochemistry, having authored 95 papers that have together received 3.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (22 papers), Genetic Associations and Epidemiology (19 papers), Genomics and Rare Diseases (9 papers), Pharmaceutical studies and practices (7 papers), Hormonal Regulation and Hypertension (7 papers), Cardiovascular Function and Risk Factors (7 papers), Inflammatory Bowel Disease (7 papers) and Drug Transport and Resistance Mechanisms (5 papers). The work is most often cited by research in Pharmacology (987 citations), Genetics (1.5k citations) and Pediatrics, Perinatology and Child Health (678 citations). Ulrich Broeckel has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Kristine R. Crews, Mary V. Relling, William E. Evans, James M. Hoffman, Heribert Schunkert, Scott C. Howard, Donna K. Arnett, Howard J. Jacob, Amy Turner and Cyrine E. Haidar. Their work appears in journals such as Circulation, Nature Communications and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.